SCHEMBL23904459

SCHEMBL23904459

COc1cc(-n2c(C(C)C)cc3nc(N)c(C=N)cc32)ccc1F

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 1/20 0.33
PIK3CD O00329 1/20 0.32
ABL1 P00519 1/20 0.32
EGFR P00533 1/20 0.32
HCK P08631 1/20 0.32
SRC P12931 1/20 0.32
KDR P35968 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
MTOR P42345 1/20 0.32
PIK3CG P48736 1/20 0.32
EPHB4 P54760 1/20 0.32
PRKDC P78527 1/20 0.32
PI4KB Q9UBF8 1/20 0.32
DHFR P00374 2/20 0.32
P2RX3 P56373 1/20 0.31
P2RX2 Q9UBL9 1/20 0.31
CYP1A2 P05177 1/20 0.30
PDE10A Q9Y233 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30176976 0.76 PDE4B (0.36) PDE4BCYP1A2PDE10ATSHRALDH3A1
SCHEMBL23887931 0.76 PDE4B (0.36) PDE4BCYP1A2PDE10ATSHRALDH3A1
SCHEMBL30176953 0.69 PDE4B (0.36) PDE4B
SCHEMBL23887974 0.69 PDE4B (0.36) PDE4B
SCHEMBL21901135 0.68 PIK3CA (0.31) PIK3CA
SCHEMBL25560993 0.68 CACNA1H (0.40) PDE4BPDE10A
SCHEMBL23887995 0.67 TLR8 (0.40) SRCPIK3CA
SCHEMBL30177050 0.67 TLR8 (0.40) SRCPIK3CA
SCHEMBL21900954 0.66 NOTUM (0.32) PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL23886957 0.66 PIK3CA (0.34) PDE4BPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021203010-A1 PYRROLO[2,3-F]INDAZOLE AND 2,4,5,10-TETRAZATRICYCLO[7.3.0.03,7]DODECA-1,3(7),5,8,11-PENTAENE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD) VERTEX PHARMACEUTICALS INCORPORATED (US) 2021-10-07 WO disclosed